ICGC Data Portal
The International Cancer Genome Consortium (ICGC) is a collaborative effort to characterize genomic abnormalities in 50 different cancer types. Currently has data from 24 cancer projects. Open access data (eg. Somatic mutations, copy number alterations, structural rearrangements, gene expression, miRNAs). Easy to search and analyze data, construct queries across multiple data sets.
Description
More detailed information about this field from each metasource.
The International Cancer Genome Consortium (ICGC) is a collaborative effort to characterize genomic abnormalities in 50 different cancer types. Currently has data from 24 cancer projects. Open access data (eg. Somatic mutations, copy number alterations, structural rearrangements, gene expression, miRNAs). Easy to search and analyze data, construct queries across multiple data sets.
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:34:19.576107
Webpage:
http://dcc.icgc.org/Webpage
More detailed information about this field from each metasource.
Publications:
Publications
More detailed information about this field from each metasource.
International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data
PMID: 21930502
metasource: bio.tools
version: extracted_at: 2022-11-04T11:34:19.576107
Publications
More detailed information about this field from each metasource.
International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data
PMID: 21930502
metasource: bio.tools
version: extracted_at: 2022-11-04T11:34:19.576107
-
International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data
PubMed citations: 252.
252 articles citing: International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data
Deep Learning-Based Pan-Cancer Classification Model Reveals Tissue-of-Origin Specific Gene Expression Signatures. PMID:35267493
Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases. PMID:35251978
DBHR: a collection of databases relevant to human research. PMID:35251694
Novel insight into pancreatic adenocarcinoma pathogenesis using liquid association analysis. PMID:35180880
In silico recognition of a prognostic signature in basal-like breast cancer patients. PMID:35167614
Theranostic Interpolation of Genomic Instability in Breast Cancer. PMID:35163783
Multi-omic analysis reveals significantly mutated genes and DDX3X as a sex-specific tumor suppressor in cutaneous melanoma. PMID:35121978
Computational Prediction of the Pathogenic Status of Cancer-Specific Somatic Variants. PMID:35116056
The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients. PMID:35082522
RNF43/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-state. PMID:35039505
A Novel Angiogenesis-Related Prognostic Signature Associated with the Hepatocellular Carcinoma Immune Microenvironment and Survival Outcome. PMID:35027841
Predicting heterogeneity in clone-specific therapeutic vulnerabilities using single-cell transcriptomic signatures. PMID:34915921
Navigating Multi-Scale Cancer Systems Biology Towards Model-Driven Clinical Oncology and Its Applications in Personalized Therapeutics. PMID:34900668
Identification of Genetic Predispositions Related to Ionizing Radiation in Primary Human Skin Fibroblasts From Survivors of Childhood and Second Primary Cancer as Well as Cancer-Free Controls: Protocol for the Nested Case-Control Study KiKme. PMID:34762066
GJA1 promotes hepatocellular carcinoma progression by mediating TGF-β-induced activation and the epithelial-mesenchymal transition of hepatic stellate cells. PMID:34693020
Prostate zones and cancer: lost in transition? PMID:34667303
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma. PMID:34651586
SomaMutDB: a database of somatic mutations in normal human tissues. PMID:34634815
Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery. PMID:34631760
CPLM 4.0: an updated database with rich annotations for protein lysine modifications. PMID:34581824
Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer. PMID:34446052
Transcriptional Regulation of RUNX1: An Informatics Analysis. PMID:34440349
Molecular Subtypes of Oral Squamous Cell Carcinoma Based on Immunosuppression Genes Using a Deep Learning Approach. PMID:34422810
Application of NGS Technology in Understanding the Pathology of Autoimmune Diseases. PMID:34362117
A Personalized Therapeutics Approach Using an In Silico Drosophila Patient Model Reveals Optimal Chemo- and Targeted Therapy Combinations for Colorectal Cancer. PMID:34336681
UCSCXenaShiny: An R/CRAN Package for Interactive Analysis of UCSC Xena Data. PMID:34323947
Distinct signatures of codon and codon pair usage in 32 primary tumor types in the novel database CancerCoCoPUTs for cancer-specific codon usage. PMID:34321100
CNVIntegrate: the first multi-ethnic database for identifying copy number variations associated with cancer. PMID:34259866
Identifying Cancer Drivers Using DRIVE: A Feature-Based Machine Learning Model for a Pan-Cancer Assessment of Somatic Missense Mutations. PMID:34205004
Integrative Transcriptomic Analysis Reveals Distinctive Molecular Traits and Novel Subtypes of Collecting Duct Carcinoma. PMID:34200770
Advancing clinical genomics and precision medicine with GVViZ: FAIR bioinformatics platform for variable gene-disease annotation, visualization, and expression analysis. PMID:34174938
Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies. PMID:34123788
Human MettL3-MettL14 RNA adenine methyltransferase complex is active on double-stranded DNA containing lesions. PMID:34086966
Sequence Neighborhoods Enable Reliable Prediction of Pathogenic Mutations in Cancer Genomes. PMID:34068918
Biomarker Identification through Multiomics Data Analysis of Prostate Cancer Prognostication Using a Deep Learning Model and Similarity Network Fusion. PMID:34064004
Analysis and Interpretation of the Impact of Missense Variants in Cancer. PMID:34063805
driveR: a novel method for prioritizing cancer driver genes using somatic genomics data. PMID:34030627
Epigenetic dysregulation of immune-related pathways in cancer: bioinformatics tools and visualization. PMID:33963293
Evaluating the transcriptional fidelity of cancer models. PMID:33926541
Detailed evaluation of cancer sequencing pipelines in different microenvironments and heterogeneity levels. PMID:33907494
Deletion of CTCF sites in the SHH locus alters enhancer-promoter interactions and leads to acheiropodia. PMID:33863876
High ELF4 expression in human cancers is associated with worse disease outcomes and increased resistance to anticancer drugs. PMID:33836003
Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features. PMID:33799792
Mutational signatures associated with exposure to carcinogenic microplastic compounds bisphenol A and styrene oxide. PMID:33718875
Assessing the contribution of tumor mutational phenotypes to cancer progression risk. PMID:33711014
Characterization of SALL2 Gene Isoforms and Targets Across Cell Types Reveals Highly Conserved Networks. PMID:33692826
Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients. PMID:33662628
Online informatics resources to facilitate cancer target and chemical probe discovery. PMID:33479663
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma. PMID:33431814
A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions. PMID:33431024
Untangling a complex web: Computational analyses of tumor molecular profiles to decode driver mechanisms. PMID:33423960
Pannexin 1 mutation found in melanoma tumor reduces phosphorylation, glycosylation, and trafficking of the channel-forming protein. PMID:33405952
Analysis of Pan-omics Data in Human Interactome Network (APODHIN). PMID:33363571
State of the Field in Multi-Omics Research: From Computational Needs to Data Mining and Sharing. PMID:33362867
Identifying Clear Cell Renal Cell Carcinoma Coexpression Networks Associated with Opioid Signaling and Survival. PMID:33318038
Discovering novel driver mutations from pan-cancer analysis of mutational and gene expression profiles. PMID:33232371
e-MutPath: computational modeling reveals the functional landscape of genetic mutations rewiring interactome networks. PMID:33211847
Artificial Intelligence (AI)-Based Systems Biology Approaches in Multi-Omics Data Analysis of Cancer. PMID:33154949
Prediction of driver variants in the cancer genome via machine learning methodologies. PMID:33094325
Evaluation of the potential role of long non-coding RNA LINC00961 in luminal breast cancer: a case-control and systems biology study. PMID:33024416
First description of ultramutated endometrial cancer caused by germline loss-of-function and somatic exonuclease domain mutations in POLE gene. PMID:33001133
Network and Systems Medicine: Position Paper of the European Collaboration on Science and Technology Action on Open Multiscale Systems Medicine. PMID:32954378
Gene signatures and prognostic values of m1A-related regulatory genes in hepatocellular carcinoma. PMID:32934298
MONET: Multi-omic module discovery by omic selection. PMID:32931516
Comprehensive analysis of structural variants in breast cancer genomes using single-molecule sequencing. PMID:32887686
Clinical Application of Targeted Deep Sequencing in Metastatic Colorectal Cancer Patients: Actionable Genomic Alteration in K-MASTER Project. PMID:32810930
Strength of immune selection in tumors varies with sex and age. PMID:32807809
A compendium of mutational cancer driver genes. PMID:32778778
A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapy prediction in neurooncology. PMID:32758285
Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms. PMID:32640014
Comparison of unsupervised machine-learning methods to identify metabolomic signatures in patients with localized breast cancer. PMID:32637048
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients. PMID:32631229
High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival. PMID:32602248
Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma. PMID:32512514
Human gene and disease associations for clinical-genomics and precision medicine research. PMID:32508008
UGT2B17 modifies drug response in chronic lymphocytic leukaemia. PMID:32418995
An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors. PMID:32406930
Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in ER-positive, HER2-negative Breast Cancer Patients. PMID:32369904
Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks. PMID:32364237
PDZ Domains as Drug Targets. PMID:32313833
CScape-somatic: distinguishing driver and passenger point mutations in the cancer genome. PMID:32282885
Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma. PMID:32221016
Gene Expression Alterations and Molecular Analysis of CHEK1 in Solid Tumors. PMID:32178478
CancerLivER: a database of liver cancer gene expression resources and biomarkers. PMID:32147717
Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint. PMID:32108164
DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma. PMID:32071398
A census of pathway maps in cancer systems biology. PMID:32066900
Exploration of databases and methods supporting drug repurposing: a comprehensive survey. PMID:32055842
Identification of cancer driver genes based on nucleotide context. PMID:32015527
Machine Learning and Network Analyses Reveal Disease Subtypes of Pancreatic Cancer and their Molecular Characteristics. PMID:31988390
An ancestry informative marker panel design for individual ancestry estimation of Hispanic population using whole exome sequencing data. PMID:31888480
Membrane Anchoring of Hck Kinase via the Intrinsically Disordered SH4-U and Length Scale Associated with Subcellular Localization. PMID:31877324
FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures. PMID:31847917
Evaluating the consistency of large-scale pharmacogenomic studies. PMID:31846027
GenoSurf: metadata driven semantic search system for integrated genomic datasets. PMID:31820804
mitoXplorer, a visual data mining platform to systematically analyze and visualize mitochondrial expression dynamics and mutations. PMID:31799603
Cancer Is Associated with Alterations in the Three-Dimensional Organization of the Genome. PMID:31783642
Epigenomics of Pancreatic Cancer: A Critical Role for Epigenome-Wide Studies. PMID:31772762
Ontology-based prediction of cancer driver genes. PMID:31757986
Metabolic gene alterations impact the clinical aggressiveness and drug responses of 32 human cancers. PMID:31754644
Defining Signatures of Arm-Wise Copy Number Change and Their Associated Drivers in Kidney Cancers. PMID:31744086
Uncovering the subtype-specific temporal order of cancer pathway dysregulation. PMID:31710622
PyGMQL: scalable data extraction and analysis for heterogeneous genomic datasets. PMID:31703553
LncRNAs as Chromatin Regulators in Cancer: From Molecular Function to Clinical Potential. PMID:31658672
Bringing radiomics into a multi-omics framework for a comprehensive genotype-phenotype characterization of oncological diseases. PMID:31590671
LOTUS: A single- and multitask machine learning algorithm for the prediction of cancer driver genes. PMID:31568528
Mutation profiling of cancer drivers in Brazilian colorectal cancer. PMID:31548566
Biclustering-based association rule mining approach for predicting cancer-associated protein interactions. PMID:31538957
3D spatial organization and network-guided comparison of mutation profiles in Glioblastoma reveals similarities across patients. PMID:31527881
Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer. PMID:31506430
Statistical genomics in rare cancer. PMID:31437624
Clustering analysis of microRNA and mRNA expression data from TCGA using maximum edge-weighted matching algorithms. PMID:31382962
Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal Adenocarcinoma. PMID:31379917
Inactivation of Prostaglandin E2 as a Mechanism for UGT2B17-Mediated Adverse Effects in Chronic Lymphocytic Leukemia. PMID:31334126
Integration of Random Forest Classifiers and Deep Convolutional Neural Networks for Classification and Biomolecular Modeling of Cancer Driver Mutations. PMID:31245384
An overview of publicly available patient-centered prostate cancer datasets. PMID:31143673
Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary Melanomas. PMID:31058252
ClinOmicsTrailbc: a visual analytics tool for breast cancer treatment stratification. PMID:31038669
Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance. PMID:31036064
Impact of Genetic Variation on CRISPR-Cas Targeting. PMID:31021199
Integrated transcriptome interactome study of oncogenes and tumor suppressor genes in breast cancer. PMID:30906836
The International Cancer Genome Consortium Data Portal. PMID:30877282
TACCO, a Database Connecting Transcriptome Alterations, Pathway Alterations and Clinical Outcomes in Cancers. PMID:30846808
Advancing Personalized Medicine Through the Application of Whole Exome Sequencing and Big Data Analytics. PMID:30809243
Modeling double strand break susceptibility to interrogate structural variation in cancer. PMID:30736820
Data mining for mutation-specific targets in acute myeloid leukemia. PMID:30728456
NEMO: cancer subtyping by integration of partial multi-omic data. PMID:30698637
Data Lakes, Clouds, and Commons: A Review of Platforms for Analyzing and Sharing Genomic Data. PMID:30691868
Interaction of germline variants in a family with a history of early-onset clear cell renal cell carcinoma. PMID:30680959
Use case driven evaluation of open databases for pediatric cancer research. PMID:30675185
Systematics for types and effects of DNA variations. PMID:30591019
ALKBH5 gene is a novel biomarker that predicts the prognosis of pancreatic cancer: A retrospective multicohort study. PMID:30588520
Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors. PMID:30531873
Systematic identification of mutations and copy number alterations associated with cancer patient prognosis. PMID:30526857
Genes at the Crossroad of Primary Immunodeficiencies and Cancer. PMID:30443258
Integrative genomic analysis of mouse and human hepatocellular carcinoma. PMID:30287485
Launching the C-HPP neXt-CP50 Pilot Project for Functional Characterization of Identified Proteins with No Known Function. PMID:30269496
Multimodal Meta-Analysis of 1,494 Hepatocellular Carcinoma Samples Reveals Significant Impact of Consensus Driver Genes on Phenotypes. PMID:30242023
A machine learning approach for somatic mutation discovery. PMID:30185652
Pan-Cancer Analysis Reveals Differential Susceptibility of Bidirectional Gene Promoters to DNA Methylation, Somatic Mutations, and Copy Number Alterations. PMID:30081598
Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family. PMID:30072699
Explaining cancer type specific mutations with transcriptomic and epigenomic features in normal tissues. PMID:30061703
Toward mapping the human body at a cellular resolution. PMID:30058989
Targeted Next-Generation Sequencing Identifies Actionable Targets in Estrogen Receptor Positive and Estrogen Receptor Negative Endometriod Endometrial Cancer. PMID:30057548
BioMuta and BioXpress: mutation and expression knowledgebases for cancer biomarker discovery. PMID:30053270
TC3A: The Cancer 3' UTR Atlas. PMID:30053266
Epigenetic and transcriptional dysregulation of VWA2 associated with a MYC-driven oncogenic program in colorectal cancer. PMID:30038405
S100A10, a novel biomarker in pancreatic ductal adenocarcinoma. PMID:30009399
SigMat: a classification scheme for gene signature matching. PMID:29950002
Cancer-mutation network and the number and specificity of driver mutations. PMID:29895694
DEXTER: Disease-Expression Relation Extraction from Text. PMID:29860481
Combined linkage and association analysis of classical Hodgkin lymphoma. PMID:29755658
Novel functional variants at the GWAS-implicated loci might confer risk to major depressive disorder, bipolar affective disorder and schizophrenia. PMID:29745862
In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors. PMID:29632087
Finding cancer driver mutations in the era of big data research. PMID:29611034
Methylation-to-Expression Feature Models of Breast Cancer Accurately Predict Overall Survival, Distant-Recurrence Free Survival, and Pathologic Complete Response in Multiple Cohorts. PMID:29581450
MSeqDR mvTool: A mitochondrial DNA Web and API resource for comprehensive variant annotation, universal nomenclature collation, and reference genome conversion. PMID:29539190
Combinatory use of distinct single-cell RNA-seq analytical platforms reveals the heterogeneous transcriptome response. PMID:29472726
Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations. PMID:29449433
A roadmap towards personalized immunology. PMID:29423275
Stratification of TAD boundaries reveals preferential insulation of super-enhancers by strong boundaries. PMID:29416042
LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations. PMID:29325141
Expanding horizons: new roles for non-canonical RNA-binding proteins in cancer. PMID:29216518
A comprehensive analysis of breast cancer microbiota and host gene expression. PMID:29190829
Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations. PMID:29180611
iUUCD 2.0: an update with rich annotations for ubiquitin and ubiquitin-like conjugations. PMID:29106644
The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer. PMID:29061113
SBCDDB: Sleeping Beauty Cancer Driver Database for gene discovery in mouse models of human cancers. PMID:29059366
DiseaseEnhancer: a resource of human disease-associated enhancer catalog. PMID:29059320
Resources for Interpreting Variants in Precision Genomic Oncology Applications. PMID:28975082
Computational Approaches to Identify Genetic Interactions for Cancer Therapeutics. PMID:28941356
MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value. PMID:28915579
CScape: a tool for predicting oncogenic single-point mutations in the cancer genome. PMID:28912487
Prevalence of Rare Genetic Variations and Their Implications in NGS-data Interpretation. PMID:28851938
Integrated Genomic Medicine: A Paradigm for Rare Diseases and Beyond. PMID:28838357
The CINSARC signature as a prognostic marker for clinical outcome in multiple neoplasms. PMID:28710396
Cell signalling pathway regulation by RanBPM: molecular insights and disease implications. PMID:28659384
Quantification of within-sample genetic heterogeneity from SNP-array data. PMID:28607403
Bioinformatics in translational drug discovery. PMID:28487472
mTCTScan: a comprehensive platform for annotation and prioritization of mutations affecting drug sensitivity in cancers. PMID:28482068
GSuite HyperBrowser: integrative analysis of dataset collections across the genome and epigenome. PMID:28459977
Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. PMID:28445466
Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer. PMID:28423713
Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer. PMID:28423671
Omicseq: a web-based search engine for exploring omics datasets. PMID:28402462
Toil enables reproducible, open source, big biomedical data analyses. PMID:28398314
Combinatorial Ranking of Gene Sets to Predict Disease Relapse: The Retinoic Acid Pathway in Early Prostate Cancer. PMID:28361034
Identification of a Novel Somatic Mutation Leading to Allele Dropout for EGFR L858R Genotyping in Non-Small Cell Lung Cancer. PMID:28357677
How do messenger RNA splicing alterations drive myelodysplasia? PMID:28348147
Visual Display of 5p-arm and 3p-arm miRNA Expression with a Mobile Application. PMID:28271066
Population and clinical genetics of human transposable elements in the (post) genomic era. PMID:28228978
Identification of coding and non-coding mutational hotspots in cancer genomes. PMID:28056774
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. PMID:27993330
A cloud-based workflow to quantify transcript-expression levels in public cancer compendia. PMID:27982081
The ability of human nuclear DNA to cause false positive low-abundance heteroplasmy calls varies across the mitochondrial genome. PMID:27955616
DoCM: a database of curated mutations in cancer. PMID:27684579
Databases and tools for constructing signal transduction networks in cancer. PMID:27502015
RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4. PMID:27282075
Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma. PMID:27280393
Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis. PMID:27137215
Omics Profiling in Precision Oncology. PMID:27099341
Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent Sequencing. PMID:27077911
BRONCO: Biomedical entity Relation ONcology COrpus for extracting gene-variant-disease-drug relations. PMID:27074804
OASIS: web-based platform for exploring cancer multi-omics data. PMID:26716558
3D Chromosome Regulatory Landscape of Human Pluripotent Cells. PMID:26686465
Immunoinformatics and epitope prediction in the age of genomic medicine. PMID:26589500
BreCAN-DB: a repository cum browser of personalized DNA breakpoint profiles of cancer genomes. PMID:26586806
Prediction of Genetic Interactions Using Machine Learning and Network Properties. PMID:26579514
The potential role of PHF6 as an oncogene: a genotranscriptomic/proteomic meta-analysis. PMID:26561469
Human genotype-phenotype databases: aims, challenges and opportunities. PMID:26553330
Oncogenomic portals for the visualization and analysis of genome-wide cancer data. PMID:26484415
Building the foundation for genomics in precision medicine. PMID:26469044
Sequence Factorization with Multiple References. PMID:26422374
The search for cis-regulatory driver mutations in cancer genomes. PMID:26356674
The Matchmaker Exchange: a platform for rare disease gene discovery. PMID:26295439
CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer. PMID:26253137
Sharing and Reuse of Sensitive Data and Samples: Supporting Researchers in Identifying Ethical and Legal Requirements. PMID:26186169
On-Demand Indexing for Referential Compression of DNA Sequences. PMID:26146838
Computational methods and resources for the interpretation of genomic variants in cancer. PMID:26111056
SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering. PMID:25903787
The BioMart community portal: an innovative alternative to large, centralized data repositories. PMID:25897122
Generating a focused view of disease ontology cancer terms for pan-cancer data integration and analysis. PMID:25841438
Cytoplasmic accumulation of NCoR in malignant melanoma: consequences of altered gene repression and prognostic significance. PMID:25823659
BioXpress: an integrated RNA-seq-derived gene expression database for pan-cancer analysis. PMID:25819073
Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data. PMID:25785493
Mining CK2 in cancer. PMID:25541719
Molecular characterization of serous ovarian carcinoma using a multigene next generation sequencing cancer panel approach. PMID:25404506
Human cancer databases (review). PMID:25369839
Systems biology of cancer: a challenging expedition for clinical and quantitative biologists. PMID:25191654
Blocking and randomization to improve molecular biomarker discovery. PMID:24788100
A framework for organizing cancer-related variations from existing databases, publications and NGS data using a High-performance Integrated Virtual Environment (HIVE). PMID:24667251
NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes. PMID:24608173
Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing. PMID:24418928
Natural variation in the histone demethylase, KDM4C, influences expression levels of specific genes including those that affect cell growth. PMID:24285722
The pancreatic expression database: recent extensions and updates. PMID:24163255
IntOGen-mutations identifies cancer drivers across tumor types. PMID:24037244
ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors. PMID:23650517
A self-updating road map of The Cancer Genome Atlas. PMID:23595662
Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ. PMID:23477556
APOBEC3B is an enzymatic source of mutation in breast cancer. PMID:23389445
The International Serious Adverse Events Consortium's data sharing model. PMID:23302924
Improving the prediction of the functional impact of cancer mutations by baseline tolerance transformation. PMID:23181723
Adaptive efficient compression of genomes. PMID:23146997
Functional impact bias reveals cancer drivers. PMID:22904074
Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas. PMID:22610075
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. PMID:22588877
DIPSBC--data integration platform for systems biology collaborations. PMID:22568834
Full-Length Enrich c-DNA Libraries-Clear Cell-Renal Cell Carcinoma. PMID:22545051
BioMart: driving a paradigm change in biological data management. PMID:22083790
The Reactome BioMart. PMID:22012987
BioMart Central Portal: an open database network for the biological community. PMID:21930507
BioMart: a data federation framework for large collaborative projects. PMID:21930506
Tags:
Tags
More detailed information about this field from each metasource.
oncology
metasource: bio.tools
version: extracted_at: 2022-11-04T11:34:19.576107
genetic variation
metasource: bio.tools
version: extracted_at: 2022-11-04T11:34:19.576107
functional, regulatory and non-coding rna
metasource: bio.tools
version: extracted_at: 2022-11-04T11:34:19.576107
gene transcripts
metasource: bio.tools
version: extracted_at: 2022-11-04T11:34:19.576107
Tags
More detailed information about this field from each metasource.
oncology
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:34:19.576107
genetic variation
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:34:19.576107
functional, regulatory and non-coding rna
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:34:19.576107
gene transcripts
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:34:19.576107
oncology genetic variation functional, regulatory and non-coding rna gene transcripts
Need help integrating and/or managing biomedical data?